Indivior Pharmaceuticals (INDV) Revenue (2024 - 2026)
Indivior Pharmaceuticals' Revenue was $343 million in Q2 2026, up 13.6% from $302 million a year earlier and up 8.2% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Revenue (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Indivior Pharmaceuticals' Revenue was $1.33 billion through Jun 30, 2026, up 13.5% year-over-year; for FY2025, it came in at $1.24 billion, up 4.3% from FY2024.
- Revenue has now increased for four consecutive years, with a four-year compound annual growth rate of 11.9% (FY2021 to FY2025).
- In earlier years, Revenue was $1.19 billion in FY2024 (+8.7%), $1.09 billion in FY2023 (+21.3%), $901 million in FY2022 (+13.9%) and $791 million in FY2021.
- Quarterly Revenue has moved between $266 million (Q1 2025) and $358 million (Q4 2025) over five years.
- Compared with a year earlier, Revenue has increased for five straight quarters, with growth averaging 8.2% over the last six quarters.
- Per Business Quant data, INDV's Revenue in the three quarters before Q2 2026 was $317 million (Q1 2026), $358 million (Q4 2025) and $314 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Indivior Pharmaceuticals | 4.35 Bn | 3.32 Bn | 294.00 Mn | 343.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 343.00 Mn |
| Mar 31, 2026 | 317.00 Mn |
| Dec 31, 2025 | 358.00 Mn |
| Sep 30, 2025 | 314.00 Mn |
| Jun 30, 2025 | 302.00 Mn |
| Mar 31, 2025 | 266.00 Mn |
| Dec 31, 2024 | 299.00 Mn |
| Sep 30, 2024 | 307.00 Mn |
| Jun 30, 2024 | 299.00 Mn |
| Mar 31, 2024 | 284.00 Mn |
API Access
Indivior Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();